Controlled release chitosan microspheres of mirtazapine: In vitro and in vivo evaluation

Archives of Pharmacal Research

Volumn 34, Issue 11, 2011, Pages 1919-1929

  Ranjan, Om Prakash ^a   Shavi, Gopal Venkatesh ^a   Nayak, Usha Yogendra ^a   Arumugam, Karthik ^a   Averineni, Ranjith Kumar ^a   Meka, Sreenivasa Reddy ^a   Sureshwar, Pandey ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Chitosan; Glutaraldehyde; Microspheres; Mirtazapine; Pharmacokinetics

Indexed keywords

CHITOSAN; MICROSPHERE; MIRTAZAPINE;

AREA UNDER THE CURVE; ARTICLE; CONTROLLED RELEASE FORMULATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; EMULSION; ENCAPSULATION; IN VIVO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; PARTICLE SIZE; RAT; SYSTEMIC CIRCULATION;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BIOLOGICAL AVAILABILITY; CHITOSAN; CROSS-LINKING REAGENTS; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG STABILITY; GLUTARAL; HALF-LIFE; HOT TEMPERATURE; INJECTIONS, INTRAMUSCULAR; MALE; METABOLIC CLEARANCE RATE; MIANSERIN; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PHYSICOCHEMICAL PHENOMENA; RATS; RATS, WISTAR;

EID: 83655191900     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-1112-1     Document Type: Article

References (23)

1. J. Akbuǧa N. Bergişadi 1996 5-Fluorouracil-loaded chitosan microspheres: preparation and release characteristics J. Microencapsul. 13 161 168 8999121 10.3109/02652049609052904 (Pubitemid 26121877)
2. J. Akbuǧa N. Bergişadi 1999 Effect of formulation variables on cis-platin loaded chitosan microsphere properties J. Microencapsul. 16 697 703 10575622 10.1080/026520499288645 (Pubitemid 29478949)
3. J. Berger M. Reist J. M. Mayer O. Felt N. A. Peppas R. Gurny 2004 Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications Eur. J. Pharm. Biopharm. 57 19 34 14729078 10.1016/S0939-6411(03)00161-9 1:CAS:528:DC%2BD2cXjsFaluw%3D%3D (Pubitemid 38058801)
4. st Eds., vol. 1, Indian edition, Lippincott Williams and Wilkins (Eds.). BI Publications Pvt Ltd, India, pp. 702-719, (2005).
5. K. G. Desai H. J. Park 2005 Preparation of cross-linked chitosan microspheres by spray drying: effect of cross-linking agent on the properties of spray dried microspheres J. Microencapsul. 22 377 395 16214786 10.1080/02652040500100139 1:CAS:528:DC%2BD2MXhtV2htL3N (Pubitemid 41581877)
6. S. Dhawan A. K. Singla 2003 Nifedipine loaded chitosan microspheres prepared by emulsification phase-separation Biotech. Histochem. 78 243 254 14989642 1:CAS:528:DC%2BD2cXitVyrur8%3D (Pubitemid 38208269)
7. I. Genta P. Perugini F. Pavanetto 1998 Different molecular weight chitosan microspheres: influence on drug loading and drug release Drug Dev. Ind. Pharm. 24 779 784 9876526 10.3109/03639049809082726 1:CAS:528: DyaK1cXktl2itbs%3D (Pubitemid 28346453)
8. J. H. Hamman M. Stander A. F. Kotzé 2002 Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia Int. J. Pharm. 232 235 242 11790507 10.1016/S0378-5173(01)00914-0 1:CAS:528:DC%2BD38XjvFCisw%3D%3D (Pubitemid 34076769)
9. S. R. Jameela T. V. Kumary A. V. Lal A. Jayakrishnan 1998 Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system J. Control. Release 52 17 24 9685932 10.1016/S0168-3659(97)00187-9 1:CAS:528:DyaK1cXhtlaktbs%3D (Pubitemid 28123169)
10. K. Morimoto H. Katsumata T. Yabuta K. Iwanaga M. Kakemi Y. Tabata Y. Ikada 2001 Evaluation of gelatin microspheres for nasal and intramuscular administrations of salmon calcitonin Eur. J. Pharm. Sci. 13 179 185 11297902 10.1016/S0928-0987(01)00094-X 1:CAS:528:DC%2BD3MXisF2qs7k%3D (Pubitemid 32288787)
11. Muzzarelli, R. A. A., Jeuniauk, C., and Gooday, G. W., Chitin in Nature and Technology. Plenum, New York, (1986).
12. Y. Nishioka S. Kyotani M. Okamura M. Miyazaki K. Okazaki S. Ohnishi Y. Yamamoto K. Ito 1990 Release characteristics of cisplatin chitosan microspheres and effect of containing chitin Chem. Pharm. Bull. (Tokyo) 38 2871 2873 1:CAS:528:DyaK3MXkvFCkuw%3D%3D (Pubitemid 20386072)
13. D. Nutt 1997 Mirtazapine: pharmacology in relation to adverse effects Acta Psychiatr. Scand. Suppl. 391 31 37 9265949 10.1111/j.1600-0447.1997. tb05956.x 1:CAS:528:DyaK2sXmt1yjtLo%3D (Pubitemid 27333216)
14. H. Okada 1997 One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate Adv. Drug Deliv. Rev. 28 43 70 10837564 10.1016/S0169-409X(97)00050-1 1:CAS:528:DyaK2sXntVOjsr0%3D (Pubitemid 27497673)
15. N. A. Peppas 1985 Analysis of Fickian and non-Fickian drug release from polymers Pharm. Acta Helv. 60 110 111 4011621 1:CAS:528:DyaL2MXktFWgtb8%3D
16. M. Ramadas W. Paul K. J. Dileep Y. Anitha C. P. Sharma 2000 Lipoinsulin encapsulated alginate-chitosan capsules: intestinal delivery in diabetic rats J. Microencapsul. 17 405 411 10898081 10.1080/026520400405660 1:CAS:528: DC%2BD3cXkslOqurs%3D (Pubitemid 30420823)
17. P. L. Ritger N. A. Peppas 1987 A simple equation for description of solute release II. Fickian and anomalous release from swellable devices J. Control. Release 5 37 42 10.1016/0168-3659(87)90035-6 1:CAS:528: DyaL2sXkvVeku7s%3D (Pubitemid 17106644)
18. V. P. Shah K. K. Midha J. W. Findlay H. M. Hill J. D. Hulse I. J. McGilveray G. McKay K. J. Miller R. N. Patnaik M. L. Powell A. Tonelli C. T. Viswanathan A. Yacobi 2000 Bioanalytical method validation-a revisit with a decade of progress Pharm. Res. 17 1551 1557 11303967 10.1023/A:1007669411738 1:CAS:528:DC%2BD3MXit1egsbs%3D (Pubitemid 32217566)
19. V. R. Sinha A. K. Singla S. Wadhawan R. Kaushik R. Kumria K. Bansal S. Dhawan 2004 Chitosan microspheres as a potential carrier for drugs Int. J. Pharm. 274 1 33 15072779 10.1016/j.ijpharm.2003.12.026 1:CAS:528: DC%2BD2cXivFGlurg%3D (Pubitemid 38457003)
20. B. C. Thanoo M. C. Sunny A. Jayakrishnan 1992 Crosslinked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals J. Pharm. Pharmacol. 44 283 286 1355537 10.1111/j.2042-7158. 1992.tb03607.x 1:CAS:528:DyaK38XktFCgtr0%3D
21. C. J. Timmer J. M. Sitsen L. P. Delbressine 2001 Clinical pharmacokinetics of MTZ Clin. Pharmacokinet. 38 461 74 10.2165/00003088- 200038060-00001
22. Y. M. Wang H. Sato I. Adachi I. Horikoshi 1996 Optimization of the formulation design of chitosan microspheres containing cisplatin J. Pharm. Sci. 85 1204 1210 8923326 10.1021/js960092j 1:CAS:528:DyaK28XmtFKhtr0%3D (Pubitemid 26372889)
23. Y. Yuan B. M. Chesnutt G. Utturkar W. O. Haggard Y. Yang J. L. Ong J. D. Bumgardner 2007 The effect of cross-linking of chitosan microspheres with genipin on protein release Carbohydr. Polym. 68 561 567 10.1016/j.carbpol.2006. 10.023 1:CAS:528:DC%2BD2sXislWgs7o%3D (Pubitemid 46365939)